Mission GBM
Subscribe
Sign in
Home
Archive
About
New
Top
Results That Matter
Team Julie delivers a remarkable outcome based on leading edge clinical science
Scott L. Rakestraw, PhD
Feb 2
12
Share this post
Results That Matter
www.missiongbm.com
Copy link
Twitter
Facebook
Email
January 2023
The Central Hypothesis of Immunotherapy and Its Application to Brain Cancer
Rapid advances raise the bar on what can be achieved for patients
Scott L. Rakestraw, PhD
Jan 30
2
Share this post
The Central Hypothesis of Immunotherapy and Its Application to Brain Cancer
www.missiongbm.com
Copy link
Twitter
Facebook
Email
A Year in the Life
Charting the journey over 365 days of living with GBM
Scott L. Rakestraw, PhD
Jan 19
13
Share this post
A Year in the Life
www.missiongbm.com
Copy link
Twitter
Facebook
Email
Day One Biopharmaceuticals Announces Top Line Data for the FIREFLY-1 Pivotal Phase 2 Trial in Pediatric Low Grade Glioma
Meaningful clinical responses to tovorafenib suggest an important new tool in the Brain Cancer Toolbox
Scott L. Rakestraw, PhD
Jan 12
2
Share this post
Day One Biopharmaceuticals Announces Top Line Data for the FIREFLY-1 Pivotal Phase 2 Trial in Pediatric Low Grade Glioma
www.missiongbm.com
Copy link
Twitter
Facebook
Email
Stanford's Innovative Medicines Accelerator and The Invus Group Collaborate to Attack GBM
An important and visionary partnership featuring multiple members of Team Julie
Scott L. Rakestraw, PhD
Jan 10
4
Share this post
Stanford's Innovative Medicines Accelerator and The Invus Group Collaborate to Attack GBM
www.missiongbm.com
Copy link
Twitter
Facebook
Email
December 2022
Meet the Team: David W. Andrews, MD
Neurosurgeon "par excellence" and Biotech entrepreneur
Scott L. Rakestraw, PhD
Dec 27, 2022
5
Share this post
Meet the Team: David W. Andrews, MD
www.missiongbm.com
Copy link
Twitter
Facebook
Email
Meet the Team: Michael L. Dougan, MD, PhD
Optimizing Immuno-Oncology treatment by overcoming immune-related Adverse Events (irAEs)
Scott L. Rakestraw, PhD
Dec 21, 2022
4
Share this post
Meet the Team: Michael L. Dougan, MD, PhD
www.missiongbm.com
Copy link
Twitter
Facebook
Email
One Year Later: A Winter Celebration
We travel to the wedding of a dear friend's daughter in snowy Vermont
Scott L. Rakestraw, PhD
Dec 19, 2022
15
Share this post
One Year Later: A Winter Celebration
www.missiongbm.com
Copy link
Twitter
Facebook
Email
Big News: Moderna and Merck Report Phase 2b Data for an mRNA Cancer Vaccine + Pembrolizumab
Further Evidence that the Central Hypothesis is gaining traction in cancer immunotherapy
Scott L. Rakestraw, PhD
Dec 14, 2022
4
Share this post
Big News: Moderna and Merck Report Phase 2b Data for an mRNA Cancer Vaccine + Pembrolizumab
www.missiongbm.com
Copy link
Twitter
Facebook
Email
Podcast: The Role of T-Lymphocytes in Glioma Pathobiology
Dr. Iyad Alnahhas (Jefferson University Neuro-Oncology) interviews pediatric brain cancer pioneer Dr. David Gutmann (Washington University - St. Louis…
Scott L. Rakestraw, PhD
Dec 7, 2022
3
Share this post
Podcast: The Role of T-Lymphocytes in Glioma Pathobiology
www.missiongbm.com
Copy link
Twitter
Facebook
Email
Meet the Team: David D. Tran, MD, PhD
Chief of Neuro-Oncology, Keck Medicine of USC; Co-Director of the USC Brain Tumor Center
Scott L. Rakestraw, PhD
Dec 5, 2022
9
Share this post
Meet the Team: David D. Tran, MD, PhD
www.missiongbm.com
Copy link
Twitter
Facebook
Email
November 2022
Can We Talk? Starting Important Conversations About Increasing Investment in Brain Cancer R&D
Multiple, independent R&D streams and major investor discussions are converging on a set of new models for accelerating brain cancer therapeutics…
Scott L. Rakestraw, PhD
Nov 29, 2022
5
Share this post
Can We Talk? Starting Important Conversations About Increasing Investment in Brain Cancer R&D
www.missiongbm.com
Copy link
Twitter
Facebook
Email
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
